MediXall Group, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was USD 2,685 compared to USD 1,858 a year ago. Net loss was USD 3.420 million compared to USD 2.983 million a year ago. Basic and diluted loss per share from continuing operations was USD 0.05 compared to USD 0.05 a year ago.